Publication | Closed Access
G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE −/− mice
13
Citations
35
References
2017
Year
InflammationAnti-inflammatoryAnti-atherosclerosis EffectsMedicineImmunologyChronic InflammationApoe −/− MiceVascular BiologyLipoprotein MetabolismSynthetic Sulfonylurea CompoundPharmacologyAtherosclerosis
| Year | Citations | |
|---|---|---|
Page 1
Page 1